Skip to main content
Top
Published in: BMC Nephrology 1/2019

Open Access 01-12-2019 | Hepatitis B | Research article

Development of an electronic health record-based chronic kidney disease registry to promote population health management

Authors: Mallika L. Mendu, Salman Ahmed, Jason K. Maron, Sandhya K. Rao, Sreekanth K. Chaguturu, Megan F. May, Walter P. Mutter, Kelly A. Burdge, David J. R. Steele, David B. Mount, Sushrut S. Waikar, Jeffrey B. Weilburg, Thomas D. Sequist

Published in: BMC Nephrology | Issue 1/2019

Login to get access

Abstract

Background

Electronic health record (EHR) based chronic kidney disease (CKD) registries are central to population health strategies to improve CKD care. In 2015, Partners Healthcare System (PHS), encompassing multiple academic and community hospitals and outpatient care facilities in Massachusetts, developed an EHR-based CKD registry to identify opportunities for quality improvement, defined as improvement on both process measures and outcomes measures associated with clinical care.

Methods

Patients are included in the registry based on the following criteria: 1) two estimated glomerular filtration rate (eGFR) results < 60 ml/min/1.73m2 separated by 90 days, including the most recent eGFR being < 60 ml/min/1.73m2; or 2) the most recent two urine protein values > 300 mg protein/g creatinine on either urine total protein/creatinine ratio or urine albumin/creatinine ratio; or 3) an EHR problem list diagnosis of end stage renal disease (ESRD). The registry categorizes patients by CKD stage and includes rates of annual testing for eGFR and proteinuria, blood pressure control, use of angiotensin converting enzyme inhibitors (ACE-Is) or angiotensin receptor blockers (ARBs), nephrotoxic medication use, hepatitis B virus (HBV) immunization, vascular access placement, transplant status, CKD progression risk; number of outpatient nephrology visits, and hospitalizations.

Results

The CKD registry includes 60,503 patients and has revealed several opportunities for care improvement including 1) annual proteinuria testing performed for 17% (stage 3) and 31% (stage 4) of patients; 2) ACE-I/ARB used in 41% (stage 3) and 46% (stage 4) of patients; 3) nephrotoxic medications used among 23% of stage 4 patients; and 4) 89% of stage 4 patients lack HBV immunity. For advanced CKD patients there are opportunities to improve vascular access placement, transplant referrals and outpatient nephrology contact.

Conclusions

A CKD registry can identify modifiable care gaps across the spectrum of CKD care and enable population health strategy implementation. No linkage to Social Security Death Master File or US Renal Data System (USRDS) databases limits our ability to track mortality and progression to ESRD.
Appendix
Available only for authorised users
Literature
2.
go back to reference Hoerger TJ, Wittenborn JS, Segel JE, Burrows NR, Imai K, Eggers P, Pavkov ME, Jordan R, Hailpern SM, Schoolwerth AC, Williams DE. A health policy model of CKD: 1. Model construction, assumptions, and validation of health consequences. Am J Kidney Dis. 55(3):452–62. https://doi.org/10.1053/j.ajkd.2009.11.016 Epub 2010/02/02. PubMed PMID: 20116911. Hoerger TJ, Wittenborn JS, Segel JE, Burrows NR, Imai K, Eggers P, Pavkov ME, Jordan R, Hailpern SM, Schoolwerth AC, Williams DE. A health policy model of CKD: 1. Model construction, assumptions, and validation of health consequences. Am J Kidney Dis. 55(3):452–62. https://​doi.​org/​10.​1053/​j.​ajkd.​2009.​11.​016 Epub 2010/02/02. PubMed PMID: 20116911.
3.
go back to reference Anavekar NS, McMurray JJ, Velazquez EJ, Solomon SD, Kober L, Rouleau JL, White HD, Nordlander R, Maggioni A, Dickstein K, Zelenkofske S, Leimberger JD, Califf RM, Pfeffer MA. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med. 2004;351(13):1285–95 PubMed PMID: 15385655.CrossRefPubMed Anavekar NS, McMurray JJ, Velazquez EJ, Solomon SD, Kober L, Rouleau JL, White HD, Nordlander R, Maggioni A, Dickstein K, Zelenkofske S, Leimberger JD, Califf RM, Pfeffer MA. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med. 2004;351(13):1285–95 PubMed PMID: 15385655.CrossRefPubMed
5.
go back to reference Keith DS, Nichols GA, Gullion CM, Brown JB, Smith DH. Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med. 2004;164(6):659–63 PubMed PMID: 15037495.CrossRefPubMed Keith DS, Nichols GA, Gullion CM, Brown JB, Smith DH. Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med. 2004;164(6):659–63 PubMed PMID: 15037495.CrossRefPubMed
6.
go back to reference System USRD. USRDS 2013 Annual data report: atlas of end-stage renal disease in the United States. Bethesda: Division of Kidney U, and Hematological Diseases, National Institute of Diabetes And Digestive Kidney Diseases; 2013. System USRD. USRDS 2013 Annual data report: atlas of end-stage renal disease in the United States. Bethesda: Division of Kidney U, and Hematological Diseases, National Institute of Diabetes And Digestive Kidney Diseases; 2013.
8.
go back to reference Grant RW, Cagliero E, Sullivan CM, Dubey AK, Estey GA, Weil EM, Gesmundo J, Nathan DM, Singer DE, Chueh HC, Meigs JB. A controlled trial of population management: diabetes mellitus: putting evidence into practice (DM-PEP). Diabetes Care. 2004;27(10):2299–305 Epub 2004/09/29. PubMed PMID: 15451891.CrossRefPubMed Grant RW, Cagliero E, Sullivan CM, Dubey AK, Estey GA, Weil EM, Gesmundo J, Nathan DM, Singer DE, Chueh HC, Meigs JB. A controlled trial of population management: diabetes mellitus: putting evidence into practice (DM-PEP). Diabetes Care. 2004;27(10):2299–305 Epub 2004/09/29. PubMed PMID: 15451891.CrossRefPubMed
11.
go back to reference Wagner EH, Austin BT, Davis C, Hindmarsh M, Schaefer J, Bonomi A. Improving chronic illness care: translating evidence into action. Health Aff (Project Hope). 2001;20(6):64–78 Epub 2002/01/31. PubMed PMID: 11816692.CrossRef Wagner EH, Austin BT, Davis C, Hindmarsh M, Schaefer J, Bonomi A. Improving chronic illness care: translating evidence into action. Health Aff (Project Hope). 2001;20(6):64–78 Epub 2002/01/31. PubMed PMID: 11816692.CrossRef
14.
15.
go back to reference Rucci P, Mandreoli M, Gibertoni D, Zuccala A, Fantini MP, Lenzi J, Santoro A. A clinical stratification tool for chronic kidney disease progression rate based on classification tree analysis. Nephrol Dial Transplant. 2014;29(3):603–10. https://doi.org/10.1093/ndt/gft444 Epub 2013/11/30. PubMed PMID: 24286974.CrossRefPubMed Rucci P, Mandreoli M, Gibertoni D, Zuccala A, Fantini MP, Lenzi J, Santoro A. A clinical stratification tool for chronic kidney disease progression rate based on classification tree analysis. Nephrol Dial Transplant. 2014;29(3):603–10. https://​doi.​org/​10.​1093/​ndt/​gft444 Epub 2013/11/30. PubMed PMID: 24286974.CrossRefPubMed
16.
go back to reference Rajapurkar MM, John GT, Kirpalani AL, Abraham G, Agarwal SK, Almeida AF, Gang S, Gupta A, Modi G, Pahari D, Pisharody R, Prakash J, Raman A, Rana DS, Sharma RK, Sahoo RN, Sakhuja V, Tatapudi RR, Jha V. What do we know about chronic kidney disease in India: first report of the Indian CKD registry. BMC Nephrol. 2012;13:10. https://doi.org/10.1186/1471-2369-13-10 Epub 2012/03/07. PubMed PMID: 22390203; PMCID: PMC3350459.CrossRefPubMedPubMedCentral Rajapurkar MM, John GT, Kirpalani AL, Abraham G, Agarwal SK, Almeida AF, Gang S, Gupta A, Modi G, Pahari D, Pisharody R, Prakash J, Raman A, Rana DS, Sharma RK, Sahoo RN, Sakhuja V, Tatapudi RR, Jha V. What do we know about chronic kidney disease in India: first report of the Indian CKD registry. BMC Nephrol. 2012;13:10. https://​doi.​org/​10.​1186/​1471-2369-13-10 Epub 2012/03/07. PubMed PMID: 22390203; PMCID: PMC3350459.CrossRefPubMedPubMedCentral
17.
go back to reference Tuot DS, McCulloch CE, Velasquez A, Schillinger D, Hsu CY, Handley M, Powe NR. Impact of a primary care CKD registry in a US public safety-net health care delivery System: a pragmatic randomized trial. Am J Kidney Dis. 2018;72(2):168–77 PubMed PMID: 29699885.CrossRefPubMedPubMedCentral Tuot DS, McCulloch CE, Velasquez A, Schillinger D, Hsu CY, Handley M, Powe NR. Impact of a primary care CKD registry in a US public safety-net health care delivery System: a pragmatic randomized trial. Am J Kidney Dis. 2018;72(2):168–77 PubMed PMID: 29699885.CrossRefPubMedPubMedCentral
19.
go back to reference Sequist TD, Holliday AM, Orav EJ, Bates DW, Denker BM. Physician and patient tools to improve chronic kidney disease care. Am J Manag Care. 2018;24(4):e107–14.PubMed Sequist TD, Holliday AM, Orav EJ, Bates DW, Denker BM. Physician and patient tools to improve chronic kidney disease care. Am J Manag Care. 2018;24(4):e107–14.PubMed
20.
go back to reference Tangri N, Grams ME, Levey AS, Coresh J, Appel LJ, Astor BC, Chodick G, Collins AJ, Djurdjev O, Elley CR, Evans M, Garg AX, Hallan SI, Inker LA, Ito S, Jee SH, Kovesdy CP, Kronenberg F, Heerspink HJ, Marks A, Nadkarni GN, Navaneethan SD, Nelson RG, Titze S, Sarnak MJ, Stengel B, Woodward M, Iseki K. Multinational assessment of accuracy of equations for predicting risk of kidney failure: a meta-analysis. JAMA. 2016;315(2):164–74. https://doi.org/10.1001/jama.2015.18202 Epub 2016/01/13PubMed PMID: 26757465; PMCID: PMC4752167.CrossRefPubMedPubMedCentral Tangri N, Grams ME, Levey AS, Coresh J, Appel LJ, Astor BC, Chodick G, Collins AJ, Djurdjev O, Elley CR, Evans M, Garg AX, Hallan SI, Inker LA, Ito S, Jee SH, Kovesdy CP, Kronenberg F, Heerspink HJ, Marks A, Nadkarni GN, Navaneethan SD, Nelson RG, Titze S, Sarnak MJ, Stengel B, Woodward M, Iseki K. Multinational assessment of accuracy of equations for predicting risk of kidney failure: a meta-analysis. JAMA. 2016;315(2):164–74. https://​doi.​org/​10.​1001/​jama.​2015.​18202 Epub 2016/01/13PubMed PMID: 26757465; PMCID: PMC4752167.CrossRefPubMedPubMedCentral
22.
go back to reference Whittaker CF, Miklich MA, Patel RS, Fink JC. Medication safety principles and practice in CKD. Clin J Am Soc Nephrol. 2018;13(11):1738–46. Whittaker CF, Miklich MA, Patel RS, Fink JC. Medication safety principles and practice in CKD. Clin J Am Soc Nephrol. 2018;13(11):1738–46.
23.
go back to reference Saran R, Hedgeman E, Plantinga L, Burrows NR, Gillespie BW, Young EW, Coresh J, Pavkov M, Williams D, Powe NR. Establishing a national chronic kidney disease surveillance system for the United States. Clin J Am Soc Nephrol. 2010;5:152–61.CrossRefPubMed Saran R, Hedgeman E, Plantinga L, Burrows NR, Gillespie BW, Young EW, Coresh J, Pavkov M, Williams D, Powe NR. Establishing a national chronic kidney disease surveillance system for the United States. Clin J Am Soc Nephrol. 2010;5:152–61.CrossRefPubMed
24.
go back to reference Mujais SK, Story K, Brouillette J, et al. Health-related quality of life in CKD patients: correlates and evolution over time. Clin J Am Soc Nephrol. 2009;4(8):1293–301.CrossRefPubMedPubMedCentral Mujais SK, Story K, Brouillette J, et al. Health-related quality of life in CKD patients: correlates and evolution over time. Clin J Am Soc Nephrol. 2009;4(8):1293–301.CrossRefPubMedPubMedCentral
Metadata
Title
Development of an electronic health record-based chronic kidney disease registry to promote population health management
Authors
Mallika L. Mendu
Salman Ahmed
Jason K. Maron
Sandhya K. Rao
Sreekanth K. Chaguturu
Megan F. May
Walter P. Mutter
Kelly A. Burdge
David J. R. Steele
David B. Mount
Sushrut S. Waikar
Jeffrey B. Weilburg
Thomas D. Sequist
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2019
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/s12882-019-1260-y

Other articles of this Issue 1/2019

BMC Nephrology 1/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine